The immunogenicity and safety of the BBIBP-CorV (Sinopharm) inactivated SARS-COV-2 vaccine: A prospective observational study in Indonesia

被引：0
|
作者：
At Thobari, Jarir [1 ]
Sattwika, Prenali Dwisthi [2 ]
机构：
[1] Univ Gadjah Mada, Dept Pharmacol & Therapy, Fac Med Publ Hlth & Nursing, Yogyakarta, Indonesia
[2] Univ Gadjah Mada, Dept Internal Med, Fac Med Publ Hlth & Nursing, Yogyakarta, Indonesia
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1264
引用
收藏
页码：597 / 597
页数：1
相关论文
共 50 条
  • [1] Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients with Malignancy
    Ariamanesh, Mona
    Porouhan, Pejman
    PeyroShabany, Babak
    Fazilat-Panah, Danial
    Dehghani, Mansoureh
    Nabavifard, Maryam
    Hatami, Farbod
    Fereidouni, Mohammad
    Welsh, James S.
    Javadinia, Seyed Alireza
    CANCER INVESTIGATION, 2022, 40 (01) : 26 - 34
  • [2] Vaccination with the Inactivated Vaccine (Sinopharm BBIBP-CorV) Ensures Protection against SARS-CoV-2 Related Disease
    Wang, Chao
    Chen, Lin-Yi
    Lu, Qing-Bin
    Cui, Fuqiang
    VACCINES, 2022, 10 (06)
  • [3] Immunogenicity of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV; Sinopharm) And Short Term Clinical Outcomes in Vaccinated Solid Organ Transplant Recipients: A Prospective Cohort Study
    Shafiekhani, Mojtaba
    Nikoupour, Hamed
    Mirjalili, Mahtabsadat
    Roozbeh, Jamshid
    Gholami, Siavash
    TRANSPLANTATION, 2022, 106 (09) : S747 - S748
  • [4] A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome?
    Joudi, Maryam
    Moradi Binabaj, Maryam
    Porouhan, Pejman
    PeyroShabany, Babak
    Tabasi, Mohsen
    Fazilat-Panah, Danial
    Khajeh, Mahtab
    Mehrabian, Arezoo
    Dehghani, Mansoureh
    Welsh, James S.
    Keykhosravi, Batol
    Akbari Yazdi, Azam
    Ariamanesh, Mona
    Ghasemi, Ahmad
    Ferns, Gordon
    Javadinia, Seyed Alireza
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [5] A cohort study on the immunogenicity and safety of the inactivated SARS-CoV-2 vaccine (BBIBP-CorV) in patients with breast cancer: Does trastuzumab interfere with the outcome?
    Javadinia, S. A.
    Dehghani, M.
    Ariamanesh, M.
    Roudsarabi, Z.
    ANNALS OF ONCOLOGY, 2022, 33 : S225 - S225
  • [6] Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Hypertensive and/or Diabetic People Aged over 60 Years: A Prospective Open-Label Study
    Huang, Rongdong
    Liu, Xiaoqin
    Xie, Fangqin
    Li, Junrong
    Tang, Zhangbin
    Wu, Yuying
    Zhou, Peicong
    Zhang, Dongjuan
    DIABETES THERAPY, 2023, 14 (01) : 139 - 151
  • [7] Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
    Wang, Hui
    Zhang, Yuntao
    Huang, Baoying
    Deng, Wei
    Quan, Yaru
    Wang, Wenling
    Xu, Wenbo
    Zhao, Yuxiu
    Li, Na
    Zhang, Jin
    Liang, Hongyang
    Bao, Linlin
    Xu, Yanfeng
    Ding, Ling
    Zhou, Weimin
    Gao, Hong
    Liu, Jiangning
    Niu, Peihua
    Zhao, Li
    Zhen, Wei
    Fu, Hui
    Yu, Shouzhi
    Zhang, Zhengli
    Xu, Guangxue
    Li, Changgui
    Lou, Zhiyong
    Xu, Miao
    Qin, Chuan
    Wu, Guizhen
    Gao, George Fu
    Tan, Wenjie
    Yang, Xiaoming
    CELL, 2020, 182 (03) : 713 - +
  • [8] Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Hypertensive and/or Diabetic People Aged over 60 Years: A Prospective Open-Label Study
    Rongdong Huang
    Xiaoqin Liu
    Fangqin Xie
    Junrong Li
    Zhangbin Tang
    Yuying Wu
    Peicong Zhou
    Dongjuan Zhang
    Diabetes Therapy, 2023, 14 : 139 - 151
  • [9] Immunogenicity, clinical efficacy, and safety of Sinopharm (BBIBP-CorV) SARS-CoV-2 vaccine among people with multiple sclerosis receiving disease-modifying therapies: A prospective cohort study
    Harirchian, Mohammad Hossein
    Ebadi, Zahra
    Jameie, Melika
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 842 - 843
  • [10] Immunogenicity, clinical efficacy, and safety of the sinopharm (BBIBP-CorV) SARS-CoV-2 vaccine among people with multiple sclerosis receiving disease-modifying therapies: a prospective cohort study
    Jameie, Melika
    Looha, Mehdi Azizmohammad
    Ebadi, Zahra
    Amanollahi, Mobina
    Amani, Kiana
    Nobahari, Fatemeh
    Abdollahi, Alireza
    Mousavi, Marziyeh
    Pourghaz, Bahareh
    Harirchian, Mohammad Hossein
    BMC NEUROLOGY, 2024, 24 (01)
12345